NGT BioPharma Consultants is a drug development and advanced technologies consultancy firm that supports small molecules and biologics across the drug development continuum from late discovery through preclinical and clinical development, registration, commercialization, and life cycle management.

NGT BioPharma Consultants

Axtria enables efficient, resilient, and sustainable healthcare by blending information, analytics, and technology on the cloud to help life sciences organizations gain a competitive edge, improve patient outcomes, and drive business growth.

Navdeep Chadha

Jaswinder Chadha

Axtria

Precision Medicine Group is involved in drug development and access through the discipline of precision medicine, utilizing insights and specialized capabilities to enhance clinical research, manufacturing, and commercial success.

Precision Medicine Group

EVERSANA provides integrated commercial services for the life sciences sector, addressing drug pricing, promotion, access, reimbursement, adherence, and product delivery challenges.

Metric
Company Name	NGT BioPharma Consultants	Axtria	Precision Medicine Group	EVERSANA
Symbol
MSH ID	COM:NGTBIOPHARMACONSULTANTS	COM:AXTRIA	COM:PRECISIONMEDICINEGRP	COM:EVERSANA
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Healthcare & Health Services	Biotechnology	Pharmaceuticals
Country	US	US	US	US
Stage
Employee Count		3.63K
Website	ngtbiopharmaconsultants.com	axtria.com	precisionmedicinegrp.com	eversana.com
LinkedIn		axtria
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	300
Web Traffic Growth	1.52
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NGTBIOPHARMACONSULTANTS

NGT BioPharma Consultants

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue